GMABNasdaqPharmaceutical PreparationsAlso trades as GNMSF
GENMAB A/S
Financials through fiscal 2025, year ended Dec 31, 2025
$38.50+1.50 (+4.05%)
Close on Oct 19, 2026
Genmab A/S statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available
Valuation
| Market Cap | 330.68B DKK |
|---|---|
| Enterprise Value | 330.68B DKK |
Efficiency
| Employee Count | 3,029 |
|---|
Shares
| Shares Outstanding | 128,616,000 |
|---|---|
| Shares Change (YoY) | -3.04% |
| Float | 128,616,000 |
| Shares Held by Insiders | 0.00% |
| Shares Held by Institutions | 79.5% |
Calculated by StockData from Genmab A/S's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.